{
 "@context": "https://clearank.com/llms.txt",
 "@type": "clearank:AssetAnalysis",
 "url": "https://clearank.com/stock/draftkings-dkng/",
 "dataUrl": "https://clearank.com/stock/draftkings-dkng/data.json",
 "title": "DraftKings Inc. Futures Forecast 2026: Outlook & Key Levels",
 "description": "DraftKings Inc. (DKNG) stock: Consumer Cyclical, Gambling. $10.2B market cap. AI rating, technicals, 2030 forecast and trade plans.",
 "headline": "DraftKings Inc. (DKNG)",
 "published": "2026-06-25T09:35:38+00:00",
 "modified": "2026-10-22T04:51:25.472+00:00",
 "generated": "2026-10-22T22:01:28.545Z",
 "language": "en-US",
 "publisher": {
  "name": "CleaRank",
  "url": "https://clearank.com/"
 },
 "disclaimer": "Educational and informational only; not financial advice. AI-generated analysis reviewed by Ryan Brothwell, Financial Journalist; prices delayed up to 15 minutes.",
 "asset": {
  "ticker": "DKNG",
  "name": "DraftKings Inc.",
  "type": "Common Stock",
  "exchange": "NASDAQ",
  "currency": "USD",
  "sector": "Consumer Cyclical",
  "industry": "Gambling",
  "country": "United States",
  "website": "https://www.draftkings.com"
 },
 "quote": {
  "price": 20.53,
  "previousClose": 20.48,
  "change": 0.05,
  "changePercent": 0.2441,
  "open": 20.54,
  "high": 21.115,
  "low": 20.345,
  "volume": 11586700,
  "averageVolume": 12848310,
  "marketCap": 10192201605,
  "fiftyTwoWeekHigh": 36.98,
  "fiftyTwoWeekLow": 18.35,
  "marketOpen": false,
  "asOf": "2026-10-22T04:51:25.000Z"
 },
 "statistics": {
  "pe": -55.49,
  "eps": -0.37,
  "dividendYield": 0,
  "beta": 1.608,
  "priceToSales": 1.5773178,
  "priceToBook": 17.221254,
  "revenueTtm": 6222522880,
  "grossMargin": 0.3820950850000173,
  "returnOnEquity": -0.21139
 },
 "technicals": {
  "rsi": 49.24,
  "macd": -0.6949,
  "sma50": 22.49,
  "sma200": 24.74,
  "rsiSignal": "Neutral",
  "trend": "Bearish",
  "pricePosition": "Bearish",
  "macdSignal": "Bearish",
  "rating": "Bearish"
 },
 "analysis": {
  "rating": "Sell",
  "score": 27,
  "consensus": "Sell",
  "fairValue": null,
  "analystTarget": 31,
  "analystCount": 37,
  "wallStreetConsensus": "Buy",
  "generatedAt": "2026-10-22T04:51:25.000Z",
  "priceAtAnalysis": 20.53,
  "volatility": {
   "daily": 3.32,
   "risk": "volatile"
  }
 },
 "tradePlan": {
  "bias": "Bearish",
  "conservativeEntry": 20.94,
  "aggressiveEntry": 20.53,
  "stopLoss": 22.13,
  "stopLossPercent": 5.68,
  "targets": [
   19.89,
   18.85,
   17.8
  ]
 },
 "projections": {
  "basis": "Monte Carlo simulation on historical return distribution, re-run daily; not price targets",
  "years": [
   {
    "year": 2027,
    "downside10th": 11.68,
    "base": 22.17,
    "upside90th": 42.09
   },
   {
    "year": 2028,
    "downside10th": 9.68,
    "base": 23.95,
    "upside90th": 59.27
   },
   {
    "year": 2029,
    "downside10th": 8.53,
    "base": 25.87,
    "upside90th": 78.48
   },
   {
    "year": 2030,
    "downside10th": 7.75,
    "base": 27.94,
    "upside90th": 100.64
   },
   {
    "year": 2031,
    "downside10th": 7.2,
    "base": 30.17,
    "upside90th": 126.44
   }
  ]
 },
 "faqCount": 10,
 "atAGlance": {
  "asOf": "October 22, 2026",
  "rating": "Sell",
  "score": 27,
  "evidence": [
   {
    "label": "Trend",
    "text": "Down: the price is below both its 50- and 200-day moving averages ($22.49 and $24.74)."
   },
   {
    "label": "Insiders",
    "text": "Insiders sold $86.8M and bought $3.2M over the last 18 months."
   }
  ]
 },
 "figures": {
  "asOf": "October 22, 2026",
  "earningsReaction": null,
  "insiders": {
   "windowMonths": 18,
   "soldValue": 86814537,
   "boughtValue": 3245200,
   "sales": 27,
   "purchases": 3,
   "note": "open-market transactions only; grants and option exercises excluded"
  },
  "drawdown": {
   "years": 7,
   "worstFallPercent": -85.66,
   "peak": "March 2021",
   "trough": "May 2022",
   "recoveredBy": null,
   "recoveryMonths": null,
   "belowThatPeakNowPercent": -71.33,
   "fromHighNowPercent": -71.33,
   "oneYearHoldsPositivePercent": 56,
   "dividendsReinvested": true
  },
  "seasonality": {
   "years": 8,
   "bestMonth": {
    "month": "Nov",
    "averagePercent": 12.41,
    "upYearsPercent": 86
   },
   "worstMonth": {
    "month": "Oct",
    "averagePercent": -10.12,
    "upYearsPercent": 0
   }
  },
  "correlations": null,
  "analystTargets": {
   "analysts": 37,
   "low": 20,
   "median": 31,
   "high": 76,
   "mean": 34.2,
   "buy": 31,
   "hold": 5,
   "sell": 1
  },
  "dividend": null,
  "simulation": {
   "year": 2030,
   "base": 27.94,
   "percentile10": 7.75,
   "percentile90": 100.64,
   "note": "Monte Carlo simulation outcomes, not price targets"
  }
 },
 "sources": [
  "TwelveData",
  "Wall Street consensus"
 ],
 "sections": [
  {
   "id": "ch-overview",
   "title": "The short version",
   "text": [
    "Where DKNG stands today, and what CleaRank Financial AI makes of it.",
    "DraftKings Inc. (DKNG): Sell, 27/100 on CleaRank's AI score.",
    "Figures as of October 22, 2026.",
    "CleaRank rates DraftKings Inc. (DKNG) Sell, with a model score of 27/100. The analysts' outlook lifts the score most: 31 of 37 analysts rate it a buy and the median target is 51.0% above the price. The trend holds it back most: the price is 17.01% below its 200-day average and 8.70% below its 50-day average, and the 50-day average is 9.10% below the 200-day. The 50-day average stands at $22.49 and the 200-day at $24.74. Over the past year the price fell 38.94%.",
    "Figures we compute ourselves from DKNG's own price, earnings and insider-filing history. Tap one to see it in context."
   ],
   "lists": {
    "DKNG at a glance": [
     "Trend Down: the price is below both its 50- and 200-day moving averages ($22.49 and $24.74).",
     "Insiders Insiders sold $86.8M and bought $3.2M over the last 18 months."
    ]
   }
  },
  {
   "id": "ch-price",
   "title": "Price and trading",
   "text": [
    "The chart, today's range and how far the price has moved over each period.",
    "Pick a period: each tab shows how far DKNG has moved over it, to the last close.",
    "Where DKNG sits inside today's range and its 52-week range."
   ],
   "lists": {
    "items": [
     "Price above its 50-day average › The price of $20.53 is 8.7% below the 50-day simple moving average of $22.49.",
     "Price above its 200-day average › The price is 17.0% below the 200-day simple moving average of $24.74.",
     "50-day average above the 200-day › The 50-day average ($22.49) is 9.1% below the 200-day average ($24.74), the arrangement of a falling longer-term trend.",
     "In the upper half of its 52-week range › The price sits at 12% of its 52-week range, between $18.35 and $36.98."
    ]
   }
  },
  {
   "id": "ch-fundamentals",
   "title": "Fundamentals",
   "text": [
    "Valuation against the sector, and the revenue and earnings behind it.",
    "The headline figures for DKNG.",
    "As of October 22, 2026, DKNG trades at $20.53, with a market value of $10.19B and no P/E ratio (its trailing earnings are negative).",
    "CleaRank Financial AI's reading of DKNG's valuation, growth and risks.",
    "DKNG cannot be valued on earnings, since its P/E is not meaningful: the company lost money over the last 12 months. On sales, though, the stock trades at 1.58 times, which is 16.8% below the sector median of 1.9. To put the size in context, DKNG has a market capitalisation of $10.2B and trailing earnings of -$0.37 per share.The company is losing money, with a net margin of -2.68% and an operating margin of -4.72%. With a revenue decline of 4.60%, DKNG is 11.8 percentage points slower than the sector median of 7.2%. It reports a return on equity of -21.14%, below the sector median of 12.4%. The balance sheet rounds out the picture, with debt-to-equity of 3.36.",
    "DKNG's analysts expect average EPS of $0.8829 for this fiscal year, a rise of 33.8%. For next year the average estimate is $1.70, growth of 92.1%.",
    "A typical day for DKNG moves about 3.32%, and its beta against the S&P 500 is 1.61. While the price stays under its moving averages, the trend is a headwind for anyone holding the shares. The price is 44.48% below its 52-week high of $36.98. Over the last 18 months insiders sold $86.8M of stock and bought $3.2M. Insider sales are often planned ahead or made to cover taxes on vesting shares, so they tell less than open-market purchases would.",
    "How DKNG compares with the median Consumer Cyclical stock CleaRank tracks.",
    "Price to sales vs sector: On price-to-sales, the yardstick used here in place of P/E, DKNG trades at 1.58x, -17% versus the sector average of 1.90x.",
    "Return vs SPY: Since May 9, 2025, DKNG has lost 43.3% against a gain of 37.2% for SPY.",
    "DKNG and the Consumer Cyclical sector fund over the same days.",
    "How much DKNG sells, and how much of it becomes profit.",
    "Revenue growth: Revenue grew 27.0% in FY2025 to $6.1B, from $4.8B a year earlier.",
    "Profit margin: The net margin was 0.1% in FY2025, up from -10.6% the year before.",
    "Profitable: DKNG earned $3.7M in FY2025."
   ],
   "lists": {
    "items": [
     "P/S below the sector median › The price-to-sales ratio of 1.58 is 17.0% below the sector median of 1.9.",
     "Profitable over the last 12 months › Net income over the last 12 months was $-166.9M on revenue of $6.2B, a net margin of -2.7%."
    ]
   }
  },
  {
   "id": "ch-analysis",
   "title": "AI analysis and technicals",
   "text": [
    "CleaRank's score and reasoning, the indicators behind it, and what the price moves with.",
    "The score, the reasoning behind it, and what could move the price next.",
    "DraftKings Inc. (DKNG) is in a downtrend. At $20.53, the stock sits 17.01% below its 200-day average of $24.74 and 8.70% below its 50-day average of $22.49. Its place in the 52-week range is near the bottom: the price is 11.88% above the low of $18.35 and 44.48% below the high of $36.98. Both averages point the same way, with the 50-day sitting 9.10% below the 200-day.The price is down over each of these periods: 6.55% over the past month, 10.07% over the past three months and 38.94% over the past year. The 14-day RSI of 49.2 is in the neutral zone, and the MACD line is negative.",
    "Morgan Stanley kept its Overweight rating on October 19, 2026.",
    "DKNG sits under both its 50-day ($22.49) and 200-day ($24.74) averages, and that is the reason the trend reads down. A climb back above the 50-day would be the first sign of repair, and that average is the closest level overhead, at $22.49.Below the price, the 20-day EMA at $20.24 is the next marker. The 14-day RSI of 49.2 is in the neutral band, between 40 and 60.",
    "Momentum and trend for DKNG, from its daily closes.",
    "As of October 22, 2026, with DKNG at $20.53, its 14-day RSI is 49.2 (neutral territory), its 50-day simple moving average is $22.49 and its 200-day is $24.74.",
    "Calculated by CleaRank on daily closes as of October 22, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).",
    "Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.",
    "As of October 22, 2026, DKNG's 1-year correlation of daily returns is +0.35 with S&P 500 (SPY), +0.31 with Nasdaq 100 (QQQ), +0.09 with Bitcoin (BTC) and +0.01 with gold (XAU)."
   ],
   "lists": {
    "items": [
     "RSI Neutral",
     "SMA cross Bearish",
     "Price vs SMA Bearish",
     "MACD Bearish"
    ]
   }
  },
  {
   "id": "ch-street",
   "title": "What Wall Street expects",
   "text": [
    "The analysts' target range and how their ratings split.",
    "As of October 22, 2026, 37 Wall Street analysts cover DKNG: 31 rate it a buy or strong buy, 5 a hold and 1 a sell or strong sell. Their 12-month price targets range from $20.00 to $76.00, with a median of $31.00, 51.0% above the price of $20.53.",
    "Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank."
   ],
   "tables": [
    {
     "caption": "Recent analyst rating actions on DKNG",
     "columns": [
      "Date",
      "Firm",
      "Action",
      "Rating"
     ],
     "rows": [
      {
       "label": "Oct 19, 2026",
       "cells": [
        "Morgan Stanley",
        "Maintains",
        "Overweight"
       ]
      },
      {
       "label": "Oct 19, 2026",
       "cells": [
        "Wells Fargo",
        "Maintains",
        "Overweight"
       ]
      },
      {
       "label": "Oct 12, 2026",
       "cells": [
        "Citigroup",
        "Maintains",
        "Buy"
       ]
      },
      {
       "label": "Oct 8, 2026",
       "cells": [
        "Susquehanna",
        "Maintains",
        "Positive"
       ]
      },
      {
       "label": "Oct 7, 2026",
       "cells": [
        "Macquarie",
        "Maintains",
        "Outperform"
       ]
      },
      {
       "label": "Oct 7, 2026",
       "cells": [
        "Guggenheim",
        "Maintains",
        "Buy"
       ]
      }
     ]
    }
   ],
   "lists": {
    "items": [
     "Most analysts rate it a buy › 31 of 37 analysts rate it a buy or strong buy, 5 a hold and 1 a sell.",
     "Median target above the price › The median 12-month target of $31.00 is 51.0% above the price.",
     "More buy ratings than three months ago › 31 of 37 rate it a buy now, against 29 of 36 three months ago."
    ]
   }
  },
  {
   "id": "ch-plan",
   "title": "A trade plan, if you want one",
   "text": [
    "Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.",
    "Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.",
    "Lower risk, wait for rally",
    "Higher risk, chasing the move",
    "DKNG moves about 3.3% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.",
    "Would this DKNG plan have made money the last ten times?",
    "Your entry, stop and targets are set above. Replay them against DKNG's own history and count how often the target hit before the stop.",
    "How much DKNG tends to move, against the market and on its own."
   ],
   "lists": {
    "items": [
     "Wins vs stops",
     "Best exit",
     "Max drawdown"
    ]
   },
   "links": [
    {
     "text": "Position Size",
     "url": "https://clearank.com/tools/position-size-calculator/"
    },
    {
     "text": "Stop Loss",
     "url": "https://clearank.com/tools/stop-loss-calculator/"
    },
    {
     "text": "Risk/Reward",
     "url": "https://clearank.com/tools/risk-reward-calculator/"
    },
    {
     "text": "P&L Calculator",
     "url": "https://clearank.com/tools/profit-loss-calculator/"
    },
    {
     "text": "Trailing Stop",
     "url": "https://clearank.com/tools/trailing-stop-calculator/"
    },
    {
     "text": "Fibonacci",
     "url": "https://clearank.com/tools/fibonacci-calculator/"
    },
    {
     "text": "Pivot Points",
     "url": "https://clearank.com/tools/pivot-point-calculator/"
    },
    {
     "text": "Win Rate",
     "url": "https://clearank.com/tools/breakeven-win-rate-calculator/"
    },
    {
     "text": "Expectancy",
     "url": "https://clearank.com/tools/trade-expectancy-calculator/"
    },
    {
     "text": "Replay this plan on DKNGStart free trial · $0 today",
     "url": "https://trade.clearank.com/portfolio/demo?utm_source=clearank&amp;utm_medium=cta&amp;utm_campaign=asset_plan&amp;utm_content=trial7"
    }
   ]
  },
  {
   "id": "ch-risk",
   "title": "The long record",
   "text": [
    "DKNG's worst falls and recoveries, what $10,000 became, and which months have been kind to it.",
    "As of October 22, 2026, DKNG's worst peak-to-trough fall over the last 7 years with dividends reinvested was -85.7% (March 2021 to May 2022); it is still 71.3% below that peak, and 56% of 1-year holding periods ended with a gain.",
    "From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.",
    "What $10,000 put into DKNG in July 2019 is worth now, against the same amount in the S&P 500.",
    "Against the market: DKNG trailed the S&P 500 over this period: $20,949 against $28,601.",
    "A $10,000 investment in DKNG in July 2019 would be worth about $20,949 today with dividends reinvested, compared with about $28,601 for the same investment in the S&P 500 benchmark (also with dividends reinvested).",
    "Which calendar months have been kind to DKNG, and which have not.",
    "Strongest month, November: an average of +12.41%, up in 6 of 7 years.",
    "Weakest month, October: an average of -10.12%, up in 0 of 7 years.",
    "This month, October: has averaged -10.12%, up in 0 of 7 years. Past seasonality does not repeat on schedule.",
    "Over the last 8 years, DKNG's strongest calendar month has been November (average +12.41%, up in 6 of 7 years) and its weakest October (average -10.12%, up in 0 of 7 years).",
    "Average return for each calendar month over the last 8 years, from weekly closing prices with dividends included."
   ],
   "lists": {
    "items": [
     "Average daily move under 2% › The price has moved 3.32% on an average day (30-day standard deviation of daily returns).",
     "Recovered from its worst fall › The worst fall was 85.7%, from March 2021 to May 2022; the price is still 71.3% below that peak.",
     "Most 1-year holds ended higher › 56% of 1-year holding periods in the last 7 years ended with a gain.",
     "Beat the S&P 500 since the chart begins › $10,000 invested in July 2019 is now worth $20,949, against $28,601 in the S&P 500 (SPY)."
    ]
   }
  },
  {
   "id": "ch-scenarios",
   "title": "Long-term scenarios",
   "text": [
    "Thousands of simulated paths from the price history. A range of outcomes, not a forecast.",
    "Thousands of simulated paths for $10,000 in DKNG, from its own past volatility. The shaded area holds 80% of them.",
    "CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in DKNG today could grow to about $21,599 by 2036 in the base case, with a 90th-percentile outcome near $163,863 and a 10th-percentile outcome around $2,847. Projections are statistical simulations, not guarantees.",
    "The same simulation in share prices, year by year.",
    "CleaRank's simulation projects a price near $27.94 for DKNG by 2030 in the base case, from $20.53 today (1.4x over 4 years). The 10th-percentile path ends near $7.75. These are outcomes of a Monte Carlo simulation run on DKNG's historical return distribution, not price targets, and they assume no dividends are reinvested.",
    "Method: a lognormal simulation of DKNG's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.",
    "What would DKNG do to your portfolio?",
    "Add it to what you already hold. Ten-year backtest, the drawdown it brings, and how much of it is just the S&P in disguise."
   ],
   "tables": [
    {
     "caption": "DKNG simulated price paths by year",
     "columns": [
      "Year",
      "10th percentile",
      "Base case",
      "90th percentile",
      "range base today"
     ],
     "rows": [
      {
       "label": "2027",
       "cells": [
        "$11.68",
        "$22.17",
        "$42.09",
        ""
       ]
      },
      {
       "label": "2028",
       "cells": [
        "$9.68",
        "$23.95",
        "$59.27",
        ""
       ]
      },
      {
       "label": "2029",
       "cells": [
        "$8.53",
        "$25.87",
        "$78.48",
        ""
       ]
      },
      {
       "label": "2030",
       "cells": [
        "$7.75",
        "$27.94",
        "$101",
        ""
       ]
      },
      {
       "label": "2031",
       "cells": [
        "$7.20",
        "$30.17",
        "$126",
        ""
       ]
      }
     ]
    }
   ],
   "lists": {
    "items": [
     "10-year backtest",
     "Drawdown added",
     "Correlation"
    ]
   },
   "links": [
    {
     "text": "Backtest my portfolio with DKNGStart free trial · $0 today",
     "url": "https://trade.clearank.com/portfolio/demo?utm_source=clearank&amp;utm_medium=cta&amp;utm_campaign=asset_longterm&amp;utm_content=trial7"
    }
   ]
  },
  {
   "id": "ch-insiders",
   "title": "Insider trading",
   "text": [
    "What the people running the company have bought and sold.",
    "Shares the company's directors and officers bought and sold, from their own filings.",
    "Open-market purchases above the line, sales below.",
    "Net insider selling: Insiders bought $3.2M on the open market and sold $86.8M.",
    "As of October 22, 2026, DKNG insiders reported 27 open-market sales worth $86.8M and 3 open-market purchases worth $3.2M over the last 18 months; grants and option exercises are not counted.",
    "Source: TwelveData, from SEC Form 4 filings"
   ],
   "tables": [
    {
     "caption": "Insider transactions in DKNG",
     "columns": [
      "Date",
      "Insider",
      "Type",
      "Shares",
      "Value"
     ],
     "rows": [
      {
       "label": "Sep 3, 2026",
       "cells": [
        "Jason Shand Robins Chief Executive Officer",
        "Grant",
        "12.0K",
        "-"
       ]
      },
      {
       "label": "Sep 1, 2026",
       "cells": [
        "Robert Stanton Dodge Officer",
        "Grant",
        "34.7K",
        "-"
       ]
      },
      {
       "label": "Sep 1, 2026",
       "cells": [
        "Alan Wayne Ellingson Chief Financial Officer",
        "Grant",
        "28.1K",
        "-"
       ]
      },
      {
       "label": "Sep 1, 2026",
       "cells": [
        "Paul Liberman Officer and Director",
        "Grant",
        "72.9K",
        "-"
       ]
      },
      {
       "label": "Sep 1, 2026",
       "cells": [
        "Jason Shand Robins Chief Executive Officer",
        "Grant",
        "126.6K",
        "-"
       ]
      },
      {
       "label": "Aug 19, 2026",
       "cells": [
        "Jocelyn Moore Director",
        "Sell",
        "10.8K",
        "$258.8K"
       ]
      },
      {
       "label": "Aug 12, 2026",
       "cells": [
        "Matthew Kalish Director",
        "Option",
        "383.5K",
        "$1.8M"
       ]
      },
      {
       "label": "Jul 31, 2026",
       "cells": [
        "Robert Stanton Dodge Officer",
        "Grant",
        "1.5K",
        "-"
       ]
      },
      {
       "label": "Jul 31, 2026",
       "cells": [
        "Alan Wayne Ellingson Chief Financial Officer",
        "Grant",
        "4.3K",
        "-"
       ]
      },
      {
       "label": "Jul 1, 2026",
       "cells": [
        "Robert Stanton Dodge Officer",
        "Grant",
        "1.5K",
        "-"
       ]
      },
      {
       "label": "Jun 12, 2026",
       "cells": [
        "Jason Shand Robins Chief Executive Officer",
        "Grant",
        "8.5K",
        "-"
       ]
      },
      {
       "label": "Jun 11, 2026",
       "cells": [
        "Robert Stanton Dodge Officer",
        "Sell",
        "62.5K",
        "$1.9M"
       ]
      },
      {
       "label": "Jun 11, 2026",
       "cells": [
        "Robert Stanton Dodge Officer",
        "Option",
        "62.5K",
        "$184.4K"
       ]
      },
      {
       "label": "Jun 1, 2026",
       "cells": [
        "Robert Stanton Dodge Officer",
        "Grant",
        "34.7K",
        "-"
       ]
      },
      {
       "label": "Jun 1, 2026",
       "cells": [
        "Alan Wayne Ellingson Chief Financial Officer",
        "Grant",
        "28.1K",
        "-"
       ]
      },
      {
       "label": "Jun 1, 2026",
       "cells": [
        "Paul Liberman Officer and Director",
        "Grant",
        "72.9K",
        "-"
       ]
      },
      {
       "label": "Jun 1, 2026",
       "cells": [
        "Jason Shand Robins Chief Executive Officer",
        "Grant",
        "126.6K",
        "-"
       ]
      },
      {
       "label": "May 20, 2026",
       "cells": [
        "Erik Bradbury Officer",
        "Sell",
        "862",
        "$21.8K"
       ]
      },
      {
       "label": "May 18, 2026",
       "cells": [
        "Woodrow Levin Director",
        "Sell",
        "34.2K",
        "$880.2K"
       ]
      },
      {
       "label": "May 12, 2026",
       "cells": [
        "Woodrow Levin Director",
        "Grant",
        "5.6K",
        "-"
       ]
      },
      {
       "label": "May 12, 2026",
       "cells": [
        "Jocelyn Moore Director",
        "Grant",
        "5.6K",
        "-"
       ]
      },
      {
       "label": "May 12, 2026",
       "cells": [
        "Ryan R Moore Director",
        "Grant",
        "5.6K",
        "-"
       ]
      },
      {
       "label": "May 12, 2026",
       "cells": [
        "Valerie A Mosley Director",
        "Grant",
        "5.6K",
        "-"
       ]
      },
      {
       "label": "May 12, 2026",
       "cells": [
        "Steven Joseph Murray Director",
        "Grant",
        "5.6K",
        "-"
       ]
      },
      {
       "label": "May 12, 2026",
       "cells": [
        "Harry Evans Sloan Director",
        "Grant",
        "5.6K",
        "-"
       ]
      },
      {
       "label": "May 12, 2026",
       "cells": [
        "Marni M Walden Director",
        "Grant",
        "5.6K",
        "-"
       ]
      },
      {
       "label": "May 12, 2026",
       "cells": [
        "Gregory Westin Wendt Director",
        "Grant",
        "7.6K",
        "-"
       ]
      },
      {
       "label": "May 1, 2026",
       "cells": [
        "Robert Stanton Dodge Officer",
        "Grant",
        "1.5K",
        "-"
       ]
      },
      {
       "label": "May 1, 2026",
       "cells": [
        "Alan Wayne Ellingson Chief Financial Officer",
        "Grant",
        "4.3K",
        "-"
       ]
      },
      {
       "label": "Apr 1, 2026",
       "cells": [
        "Robert Stanton Dodge Officer",
        "Grant",
        "1.5K",
        "-"
       ]
      },
      {
       "label": "Mar 13, 2026",
       "cells": [
        "Jocelyn Moore Director",
        "Sell",
        "2.2K",
        "$55.0K"
       ]
      },
      {
       "label": "Mar 11, 2026",
       "cells": [
        "Paul Liberman Officer and Director",
        "Sell",
        "484.4K",
        "$12.2M"
       ]
      },
      {
       "label": "Mar 11, 2026",
       "cells": [
        "Paul Liberman Officer and Director",
        "Option",
        "484.4K",
        "$305.2K"
       ]
      },
      {
       "label": "Mar 9, 2026",
       "cells": [
        "Matthew Kalish Officer and Director",
        "Option",
        "273.5K",
        "$899.8K"
       ]
      },
      {
       "label": "Mar 3, 2026",
       "cells": [
        "Erik Bradbury Officer",
        "Sell",
        "2.9K",
        "$70.8K"
       ]
      },
      {
       "label": "Feb 27, 2026",
       "cells": [
        "Erik Bradbury Officer",
        "Grant",
        "8.0K",
        "-"
       ]
      },
      {
       "label": "Feb 27, 2026",
       "cells": [
        "Robert Stanton Dodge Officer",
        "Grant",
        "21.7K",
        "-"
       ]
      },
      {
       "label": "Feb 27, 2026",
       "cells": [
        "Alan Wayne Ellingson Chief Financial Officer",
        "Grant",
        "9.8K",
        "-"
       ]
      },
      {
       "label": "Feb 27, 2026",
       "cells": [
        "Matthew Kalish Officer and Director",
        "Grant",
        "39.7K",
        "-"
       ]
      },
      {
       "label": "Feb 27, 2026",
       "cells": [
        "Paul Liberman Officer and Director",
        "Grant",
        "39.7K",
        "-"
       ]
      },
      {
       "label": "Feb 27, 2026",
       "cells": [
        "Jason Robins Chief Executive Officer",
        "Grant",
        "67.9K",
        "-"
       ]
      },
      {
       "label": "Feb 19, 2026",
       "cells": [
        "Erik Bradbury Officer",
        "Sell",
        "7.3K",
        "$163.5K"
       ]
      },
      {
       "label": "Feb 18, 2026",
       "cells": [
        "Paul Liberman Officer and Director",
        "Option",
        "400.0K",
        "$1.3M"
       ]
      },
      {
       "label": "Feb 18, 2026",
       "cells": [
        "Paul Liberman Officer and Director",
        "Grant",
        "200.0K",
        "-"
       ]
      },
      {
       "label": "Feb 17, 2026",
       "cells": [
        "Harry Evans Sloan Director",
        "Buy",
        "100.0K",
        "$2.2M"
       ]
      },
      {
       "label": "Feb 13, 2026",
       "cells": [
        "Erik Bradbury Officer",
        "Grant",
        "43.9K",
        "-"
       ]
      },
      {
       "label": "Feb 13, 2026",
       "cells": [
        "Robert Stanton Dodge Officer",
        "Grant",
        "25.7K",
        "-"
       ]
      },
      {
       "label": "Feb 13, 2026",
       "cells": [
        "Alan Wayne Ellingson Chief Financial Officer",
        "Grant",
        "25.0K",
        "-"
       ]
      },
      {
       "label": "Feb 13, 2026",
       "cells": [
        "Matthew Kalish Officer and Director",
        "Grant",
        "51.5K",
        "-"
       ]
      },
      {
       "label": "Feb 13, 2026",
       "cells": [
        "Paul Liberman Officer and Director",
        "Grant",
        "51.5K",
        "-"
       ]
      },
      {
       "label": "Feb 13, 2026",
       "cells": [
        "Jason Robins Chief Executive Officer",
        "Grant",
        "87.5K",
        "-"
       ]
      },
      {
       "label": "Feb 10, 2026",
       "cells": [
        "Woodrow Levin Director",
        "Grant",
        "460",
        "-"
       ]
      },
      {
       "label": "Feb 10, 2026",
       "cells": [
        "Jocelyn Moore Director",
        "Grant",
        "622",
        "-"
       ]
      },
      {
       "label": "Feb 10, 2026",
       "cells": [
        "Ryan R Moore Director",
        "Grant",
        "668",
        "-"
       ]
      },
      {
       "label": "Feb 10, 2026",
       "cells": [
        "Valerie A Mosley Director",
        "Grant",
        "553",
        "-"
       ]
      },
      {
       "label": "Feb 10, 2026",
       "cells": [
        "Steven Joseph Murray Director",
        "Grant",
        "760",
        "-"
       ]
      },
      {
       "label": "Feb 10, 2026",
       "cells": [
        "Harry Evans Sloan Director",
        "Grant",
        "507",
        "-"
       ]
      },
      {
       "label": "Feb 10, 2026",
       "cells": [
        "Marni M Walden Director",
        "Grant",
        "691",
        "-"
       ]
      },
      {
       "label": "Feb 10, 2026",
       "cells": [
        "Gregory Westin Wendt Director",
        "Grant",
        "345",
        "-"
       ]
      },
      {
       "label": "Feb 9, 2026",
       "cells": [
        "Robert Stanton Dodge Officer",
        "Grant",
        "14.2K",
        "-"
       ]
      },
      {
       "label": "Feb 9, 2026",
       "cells": [
        "Matthew Kalish Officer and Director",
        "Grant",
        "28.3K",
        "-"
       ]
      },
      {
       "label": "Feb 9, 2026",
       "cells": [
        "Paul Liberman Officer and Director",
        "Grant",
        "28.3K",
        "-"
       ]
      },
      {
       "label": "Feb 9, 2026",
       "cells": [
        "Jason Robins Chief Executive Officer",
        "Grant",
        "38.2K",
        "-"
       ]
      },
      {
       "label": "Jan 30, 2026",
       "cells": [
        "Robert Stanton Dodge Officer",
        "Grant",
        "808",
        "-"
       ]
      },
      {
       "label": "Jan 30, 2026",
       "cells": [
        "Alan Wayne Ellingson Chief Financial Officer",
        "Grant",
        "4.3K",
        "-"
       ]
      },
      {
       "label": "Jan 20, 2026",
       "cells": [
        "Robert Stanton Dodge Officer",
        "Sell",
        "52.8K",
        "$1.7M"
       ]
      },
      {
       "label": "Jan 20, 2026",
       "cells": [
        "Robert Stanton Dodge Officer",
        "Option",
        "40.1K",
        "$118.2K"
       ]
      },
      {
       "label": "Dec 31, 2025",
       "cells": [
        "Robert Stanton Dodge Officer",
        "Grant",
        "808",
        "-"
       ]
      },
      {
       "label": "Dec 10, 2025",
       "cells": [
        "Matthew Kalish Officer and Director",
        "Grant",
        "3.0M",
        "-"
       ]
      },
      {
       "label": "Dec 9, 2025",
       "cells": [
        "Paul Liberman Officer and Director",
        "Grant",
        "75.0K",
        "-"
       ]
      },
      {
       "label": "Dec 1, 2025",
       "cells": [
        "Robert Stanton Dodge Officer",
        "Sell",
        "52.8K",
        "$1.8M"
       ]
      },
      {
       "label": "Dec 1, 2025",
       "cells": [
        "Erik Bradbury Officer",
        "Grant",
        "3.8K",
        "-"
       ]
      },
      {
       "label": "Dec 1, 2025",
       "cells": [
        "Robert Stanton Dodge Officer",
        "Option",
        "66.0K",
        "$130.9K"
       ]
      },
      {
       "label": "Dec 1, 2025",
       "cells": [
        "Alan Wayne Ellingson Chief Financial Officer",
        "Grant",
        "9.8K",
        "-"
       ]
      },
      {
       "label": "Dec 1, 2025",
       "cells": [
        "Matthew Kalish Officer and Director",
        "Grant",
        "39.7K",
        "-"
       ]
      },
      {
       "label": "Dec 1, 2025",
       "cells": [
        "Paul Liberman Officer and Director",
        "Grant",
        "39.7K",
        "-"
       ]
      },
      {
       "label": "Dec 1, 2025",
       "cells": [
        "Jason Robins Chief Executive Officer",
        "Option",
        "68.0K",
        "$33"
       ]
      },
      {
       "label": "Nov 20, 2025",
       "cells": [
        "Paul Liberman Officer and Director",
        "Option",
        "89.2K",
        "$293.3K"
       ]
      },
      {
       "label": "Nov 20, 2025",
       "cells": [
        "Jason Robins Chief Executive Officer",
        "Grant",
        "13.7K",
        "-"
       ]
      },
      {
       "label": "Nov 14, 2025",
       "cells": [
        "Alan Wayne Ellingson Chief Financial Officer",
        "Sell",
        "8.4K",
        "$246.1K"
       ]
      },
      {
       "label": "Nov 11, 2025",
       "cells": [
        "Harry Evans Sloan Director",
        "Buy",
        "25.0K",
        "$757.5K"
       ]
      },
      {
       "label": "Nov 11, 2025",
       "cells": [
        "Gregory Westin Wendt Director",
        "Buy",
        "10.0K",
        "$302.7K"
       ]
      },
      {
       "label": "Nov 7, 2025",
       "cells": [
        "Robert Stanton Dodge Officer",
        "Grant",
        "14.2K",
        "-"
       ]
      },
      {
       "label": "Nov 7, 2025",
       "cells": [
        "Matthew Kalish Officer and Director",
        "Grant",
        "28.3K",
        "-"
       ]
      },
      {
       "label": "Nov 7, 2025",
       "cells": [
        "Paul Liberman Officer and Director",
        "Grant",
        "28.3K",
        "-"
       ]
      },
      {
       "label": "Nov 7, 2025",
       "cells": [
        "Jason Robins Chief Executive Officer",
        "Grant",
        "38.2K",
        "-"
       ]
      },
      {
       "label": "Nov 6, 2025",
       "cells": [
        "Robert Stanton Dodge Officer",
        "Sell",
        "52.8K",
        "$1.5M"
       ]
      },
      {
       "label": "Nov 6, 2025",
       "cells": [
        "Robert Stanton Dodge Officer",
        "Option",
        "52.8K",
        "$155.7K"
       ]
      },
      {
       "label": "Nov 6, 2025",
       "cells": [
        "Woodrow Levin Director",
        "Grant",
        "446",
        "-"
       ]
      },
      {
       "label": "Nov 6, 2025",
       "cells": [
        "Jocelyn Moore Director",
        "Grant",
        "603",
        "-"
       ]
      },
      {
       "label": "Nov 6, 2025",
       "cells": [
        "Ryan R Moore Director",
        "Grant",
        "647",
        "-"
       ]
      },
      {
       "label": "Nov 6, 2025",
       "cells": [
        "Valerie A Mosley Director",
        "Grant",
        "536",
        "-"
       ]
      },
      {
       "label": "Nov 6, 2025",
       "cells": [
        "Steven Joseph Murray Director",
        "Grant",
        "737",
        "-"
       ]
      },
      {
       "label": "Nov 6, 2025",
       "cells": [
        "Harry Evans Sloan Director",
        "Grant",
        "491",
        "-"
       ]
      },
      {
       "label": "Nov 6, 2025",
       "cells": [
        "Marni M Walden Director",
        "Grant",
        "670",
        "-"
       ]
      },
      {
       "label": "Oct 31, 2025",
       "cells": [
        "Robert Stanton Dodge Officer",
        "Grant",
        "808",
        "-"
       ]
      },
      {
       "label": "Oct 31, 2025",
       "cells": [
        "Alan Wayne Ellingson Chief Financial Officer",
        "Grant",
        "4.3K",
        "-"
       ]
      },
      {
       "label": "Oct 17, 2025",
       "cells": [
        "Robert Stanton Dodge Officer",
        "Sell",
        "52.8K",
        "$1.8M"
       ]
      },
      {
       "label": "Oct 17, 2025",
       "cells": [
        "Robert Stanton Dodge Officer",
        "Option",
        "40.1K",
        "$118.4K"
       ]
      },
      {
       "label": "Oct 1, 2025",
       "cells": [
        "Robert Stanton Dodge Officer",
        "Grant",
        "808",
        "-"
       ]
      },
      {
       "label": "Sep 12, 2025",
       "cells": [
        "Matthew Kalish Officer and Director",
        "Grant",
        "21.3K",
        "-"
       ]
      },
      {
       "label": "Sep 2, 2025",
       "cells": [
        "Robert Stanton Dodge Officer",
        "Sell",
        "105.6K",
        "$5.0M"
       ]
      },
      {
       "label": "Sep 2, 2025",
       "cells": [
        "Robert Stanton Dodge Officer",
        "Option",
        "119.3K",
        "$287.9K"
       ]
      },
      {
       "label": "Aug 29, 2025",
       "cells": [
        "Erik Bradbury Officer",
        "Grant",
        "3.8K",
        "-"
       ]
      },
      {
       "label": "Aug 29, 2025",
       "cells": [
        "Alan Wayne Ellingson Chief Financial Officer",
        "Grant",
        "9.8K",
        "-"
       ]
      },
      {
       "label": "Aug 29, 2025",
       "cells": [
        "Matthew Kalish Officer and Director",
        "Grant",
        "39.7K",
        "-"
       ]
      },
      {
       "label": "Aug 29, 2025",
       "cells": [
        "Paul Liberman Officer and Director",
        "Grant",
        "39.7K",
        "-"
       ]
      },
      {
       "label": "Aug 29, 2025",
       "cells": [
        "Jason Robins Chief Executive Officer",
        "Grant",
        "67.9K",
        "-"
       ]
      },
      {
       "label": "Aug 25, 2025",
       "cells": [
        "Jason Robins Chief Executive Officer",
        "Grant",
        "10.0K",
        "-"
       ]
      },
      {
       "label": "Aug 21, 2025",
       "cells": [
        "Ryan R Moore Director",
        "Sell",
        "76.4K",
        "$3.5M"
       ]
      },
      {
       "label": "Aug 19, 2025",
       "cells": [
        "Alan Wayne Ellingson Chief Financial Officer",
        "Sell",
        "44.7K",
        "$2.0M"
       ]
      },
      {
       "label": "Aug 15, 2025",
       "cells": [
        "Alan Wayne Ellingson Chief Financial Officer",
        "Sell",
        "5.7K",
        "$249.2K"
       ]
      },
      {
       "label": "Aug 13, 2025",
       "cells": [
        "Jocelyn Moore Director",
        "Sell",
        "4.9K",
        "$210.0K"
       ]
      },
      {
       "label": "Aug 12, 2025",
       "cells": [
        "Matthew Kalish Officer and Director",
        "Sell",
        "420.0K",
        "$18.0M"
       ]
      },
      {
       "label": "Aug 12, 2025",
       "cells": [
        "Matthew Kalish Officer and Director",
        "Option",
        "448.3K",
        "$1.4M"
       ]
      },
      {
       "label": "Aug 8, 2025",
       "cells": [
        "Robert Stanton Dodge Officer",
        "Grant",
        "14.2K",
        "-"
       ]
      },
      {
       "label": "Aug 8, 2025",
       "cells": [
        "Paul Liberman Officer and Director",
        "Grant",
        "28.3K",
        "-"
       ]
      },
      {
       "label": "Aug 8, 2025",
       "cells": [
        "Jason Robins Chief Executive Officer",
        "Grant",
        "38.2K",
        "-"
       ]
      },
      {
       "label": "Aug 5, 2025",
       "cells": [
        "Robert Stanton Dodge Officer",
        "Sell",
        "105.6K",
        "$4.7M"
       ]
      },
      {
       "label": "Aug 5, 2025",
       "cells": [
        "Robert Stanton Dodge Officer",
        "Option",
        "105.1K",
        "$332.6K"
       ]
      }
     ]
    }
   ],
   "links": [
    {
     "text": "SEC Form 4 filings",
     "url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;company=DraftKings%20Inc.&amp;type=4&amp;dateb=&amp;owner=include&amp;count=40&amp;search_text=&amp;action=getcompany"
    }
   ]
  },
  {
   "id": "ch-faq",
   "title": "Questions people ask",
   "text": [
    "Answered from the figures on this page, as of October 22, 2026."
   ]
  },
  {
   "id": "ch-related",
   "title": "Keep exploring",
   "text": [
    "Assets people compare with this one."
   ],
   "links": [
    {
     "text": "LCID Lucid Group Inc. NASDAQ $3.21 -1.83%",
     "url": "https://clearank.com/stock/lucid-group-lcid/"
    },
    {
     "text": "LVS Las Vegas Sands Corp. NYSE $37.51 -1.73%",
     "url": "https://clearank.com/stock/lvs-stock-analysis/"
    },
    {
     "text": "VSXY Victoria's Secret & Co. NYSE $89.15 +1.30%",
     "url": "https://clearank.com/stock/victorias-secret-vsxy/"
    },
    {
     "text": "ROST Ross Stores Inc NASDAQ $234.18 -1.29%",
     "url": "https://clearank.com/stock/rost-stock-analysis/"
    },
    {
     "text": "ULTA Ulta Beauty Inc NASDAQ $606.99 +0.68%",
     "url": "https://clearank.com/stock/ulta-beauty-ulta/"
    },
    {
     "text": "PHM PulteGroup, Inc. NYSE $119.50 +5.85%",
     "url": "https://clearank.com/stock/phm-stock-analysis/"
    },
    {
     "text": "XPEV XPeng Inc. NYSE $9.16 -2.14%",
     "url": "https://clearank.com/stock/xpev-stock-analysis/"
    },
    {
     "text": "DHI D.R. Horton, Inc. NYSE $138.98 -0.85%",
     "url": "https://clearank.com/stock/dhi-stock-analysis/"
    },
    {
     "text": "Gold vs Silver Analysis and Targets Head-to-head analysis →",
     "url": "https://clearank.com/compare/gold-vs-silver/"
    },
    {
     "text": "ANET vs CSCO Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/anet-vs-csco/"
    },
    {
     "text": "SNPS vs CDNS Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/snps-vs-cdns/"
    }
   ]
  }
 ],
 "faq": [
  {
   "question": "Is DraftKings Inc. (DKNG) a buy right now?",
   "answer": "A score of 27/100 gives DKNG its Sell rating. The analysts' outlook carries the score: 31 of 37 analysts rate it a buy and the median target is 51.0% above the price. The trend holds the score back, because the price is 17.01% below its 200-day average and 8.70% below its 50-day average, and the 50-day average is 9.10% below the 200-day. This describes the data on this page and is not a personal recommendation."
  },
  {
   "question": "How has DraftKings Inc. (DKNG) performed over the past year?",
   "answer": "Over the past year the price fell 38.94%. Over shorter periods it fell 10.07% in three months and fell 6.55% in the past month. It now trades 44.48% below its 52-week high of $36.98."
  },
  {
   "question": "What are the key price levels for DKNG?",
   "answer": "On the upside, DKNG meets the 50-day SMA at $22.49 first, then the 200-day SMA at $24.74. On the downside, the 20-day EMA at $20.24 comes first, followed by the 52-week low at $18.35."
  },
  {
   "question": "Does DKNG have a P/E ratio?",
   "answer": "DKNG's P/E is not meaningful, since the company posted a loss over the last 12 months. Measured on sales, its P/S of 1.58 is 16.8% under the sector median of 1.9."
  },
  {
   "question": "What do Wall Street analysts think of DKNG?",
   "answer": "Of the 37 analysts covering DKNG, 31 rate it buy, 5 hold and 1 sell. Their median 12-month target is $31.00, 51.0% above the current price."
  },
  {
   "question": "How volatile is DKNG?",
   "answer": "On an average day DKNG's price moves 3.32%, based on the 30-day standard deviation of daily returns. Measured against the S&P 500, its beta is 1.61."
  },
  {
   "question": "Are DKNG insiders buying or selling?",
   "answer": "Insiders sold $86.8M of stock over the last 18 months and bought $3.2M on the open market. Insider sales are often arranged in advance or made to cover taxes on vesting shares, so they carry less weight than open-market purchases."
  },
  {
   "question": "What is the 52-week range of DKNG?",
   "answer": "Over the past 52 weeks DKNG has traded in a range from $18.35 to $36.98. At $20.53 it sits at 12% of that span, 11.88% above the low and 44.48% below the high."
  },
  {
   "question": "Is DKNG in an uptrend?",
   "answer": "No. DraftKings Inc. (DKNG) trades at $20.53, below both its 50- and 200-day moving averages ($22.49 and $24.74). Its 14-day RSI on daily closes is 49.2, in neutral territory."
  },
  {
   "question": "What is DKNG's biggest drop in the last 7 years?",
   "answer": "DraftKings Inc. (DKNG)'s worst peak-to-trough fall over the last 7 years was -85.7%, from March 2021 to May 2022 (with dividends reinvested). It has not regained that peak yet and is still 71.3% below it. Over the same period, 56% of 1-year holding periods ended with a gain."
  }
 ],
 "related": {
  "peopleAlsoWatch": [
   {
    "ticker": "LCID",
    "name": "Lucid Group Inc. NASDAQ",
    "price": "$3.21",
    "change": "-1.83%",
    "url": "https://clearank.com/stock/lucid-group-lcid/"
   },
   {
    "ticker": "LVS",
    "name": "Las Vegas Sands Corp. NYSE",
    "price": "$37.51",
    "change": "-1.73%",
    "url": "https://clearank.com/stock/lvs-stock-analysis/"
   },
   {
    "ticker": "VSXY",
    "name": "Victoria's Secret & Co. NYSE",
    "price": "$89.15",
    "change": "+1.30%",
    "url": "https://clearank.com/stock/victorias-secret-vsxy/"
   },
   {
    "ticker": "ROST",
    "name": "Ross Stores Inc NASDAQ",
    "price": "$234.18",
    "change": "-1.29%",
    "url": "https://clearank.com/stock/rost-stock-analysis/"
   },
   {
    "ticker": "ULTA",
    "name": "Ulta Beauty Inc NASDAQ",
    "price": "$606.99",
    "change": "+0.68%",
    "url": "https://clearank.com/stock/ulta-beauty-ulta/"
   },
   {
    "ticker": "PHM",
    "name": "PulteGroup, Inc. NYSE",
    "price": "$119.50",
    "change": "+5.85%",
    "url": "https://clearank.com/stock/phm-stock-analysis/"
   },
   {
    "ticker": "XPEV",
    "name": "XPeng Inc. NYSE",
    "price": "$9.16",
    "change": "-2.14%",
    "url": "https://clearank.com/stock/xpev-stock-analysis/"
   },
   {
    "ticker": "DHI",
    "name": "D.R. Horton, Inc. NYSE",
    "price": "$138.98",
    "change": "-0.85%",
    "url": "https://clearank.com/stock/dhi-stock-analysis/"
   }
  ],
  "comparisons": [
   {
    "ticker": "Gold vs Silver Analysis and Targets",
    "name": "",
    "url": "https://clearank.com/compare/gold-vs-silver/"
   },
   {
    "ticker": "ANET vs CSCO Comparison",
    "name": "",
    "url": "https://clearank.com/compare/anet-vs-csco/"
   },
   {
    "ticker": "SNPS vs CDNS Comparison",
    "name": "",
    "url": "https://clearank.com/compare/snps-vs-cdns/"
   }
  ],
  "Newly Tracked": [
   {
    "ticker": "ROST",
    "text": "Ross Stores Inc",
    "url": "https://clearank.com/stock/rost-stock-analysis/"
   },
   {
    "ticker": "LUGDF",
    "text": "Lundin Gold Inc",
    "url": "https://clearank.com/stock/lugdf-stock-analysis/"
   },
   {
    "ticker": "KEYS",
    "text": "Keysight Technologies, Inc.",
    "url": "https://clearank.com/stock/keys-stock-analysis/"
   },
   {
    "ticker": "BRO",
    "text": "Brown & Brown Inc.",
    "url": "https://clearank.com/stock/bro-stock-analysis/"
   },
   {
    "ticker": "SYY",
    "text": "Sysco Corp.",
    "url": "https://clearank.com/stock/syy-stock-analysis/"
   }
  ],
  "Top Movers (24h)": [
   {
    "ticker": "XHLD",
    "text": "↓ 11.23%",
    "url": "https://clearank.com/stock/xhld-stock-analysis/"
   },
   {
    "ticker": "CAPR",
    "text": "↓ 11.04%",
    "url": "https://clearank.com/stock/capr-stock-analysis/"
   },
   {
    "ticker": "SPOT",
    "text": "↑ 10.43%",
    "url": "https://clearank.com/stock/spotify-spot/"
   },
   {
    "ticker": "FIL/USD",
    "text": "↓ 10.32%",
    "url": "https://clearank.com/crypto/filecoin-fil-usd/"
   },
   {
    "ticker": "SEI/USD",
    "text": "↓ 10.04%",
    "url": "https://clearank.com/crypto/sei-sei/"
   }
  ],
  "Also in Consumer Cyclical": [
   {
    "ticker": "DECK",
    "text": "Deckers Outdoor",
    "url": "https://clearank.com/stock/deckers-outdoor-deck/"
   },
   {
    "ticker": "DHI",
    "text": "D.R. Horton Inc.",
    "url": "https://clearank.com/stock/dhi-stock-analysis/"
   },
   {
    "ticker": "DKS",
    "text": "Dick’s Sporting Goods, Inc.",
    "url": "https://clearank.com/stock/dks-stock-analysis/"
   },
   {
    "ticker": "DPZ",
    "text": "Domino’s Pizza",
    "url": "https://clearank.com/stock/dominos-pizza-dpz/"
   },
   {
    "ticker": "MRDN",
    "text": "Golden Matrix Group, Inc.",
    "url": "https://clearank.com/stock/mrdn-stock-analysis/"
   }
  ]
 },
 "schema": [
  {
   "@context": "https://schema.org",
   "@graph": [
    {
     "@type": "Place",
     "@id": "https://clearank.com/#place",
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     }
    },
    {
     "@type": "Organization",
     "@id": "https://clearank.com/#organization",
     "name": "CleaRank",
     "alternateName": "CleaRank Financial AI",
     "url": "https://clearank.com",
     "description": "CleaRank is where retail traders research a trade and practice it before risking money. Its research arm, CleaRank Financial AI, publishes daily analysis, trade plans and 10-year projections for more than 1,000 stocks, ETFs, cryptocurrencies, forex pairs and commodities; each page is built from licensed market data, carries the date it was last updated and is reviewed under CleaRank's published editorial code. The CLEAR™ Score rates online brokers and prop firms on regulation, fees, platform reliability and verified trader experience. The research is free; CleaRank is paid for by subscriptions to its trading workbench (Pro $29 a month, Ultra $59 a month), with a 7-day free trial, which combines a trading simulator, a trade journal that imports from broker history, an AI coach grounded in the trader's own trades, a portfolio generator, visualizer and backtester, a prop-firm challenge auditor and 22 trading calculators and scanners. Some free content contains partner links, which are disclosed and do not affect ratings.",
     "slogan": "Clear data. Honest analysis.",
     "logo": {
      "@type": "ImageObject",
      "@id": "https://clearank.com/#logo",
      "url": "https://clearank.com/media/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "contentUrl": "https://clearank.com/media/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "caption": "CleaRank",
      "inLanguage": "en-US",
      "width": "336",
      "height": "153"
     },
     "image": {
      "@id": "https://clearank.com/#logo"
     },
     "sameAs": [
      "https://x.com/CleaRank",
      "https://www.linkedin.com/company/clearank/",
      "https://www.youtube.com/@CleaRank",
      "https://t.me/clearank"
     ],
     "email": "info@clearank.com",
     "contactPoint": [
      {
       "@type": "ContactPoint",
       "contactType": "customer support",
       "email": "info@clearank.com",
       "url": "https://clearank.com/contact/",
       "availableLanguage": "en"
      }
     ],
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     },
     "location": {
      "@id": "https://clearank.com/#place"
     },
     "knowsAbout": [
      "stock analysis",
      "ETF analysis",
      "cryptocurrency analysis",
      "forex trading",
      "trading simulation",
      "trade journaling",
      "position sizing",
      "risk management",
      "prop firm challenges",
      "online broker regulation"
     ],
     "publishingPrinciples": "https://clearank.com/editorial-code/",
     "ethicsPolicy": "https://clearank.com/editorial-code/",
     "ownershipFundingInfo": "https://clearank.com/about-us/",
     "owns": {
      "@id": "https://clearank.com/#app"
     },
     "founder": {
      "@id": "https://clearank.com/writer/shaundavidb/#person"
     }
    },
    {
     "@type": "WebSite",
     "@id": "https://clearank.com/#website",
     "url": "https://clearank.com",
     "name": "CleaRank",
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "inLanguage": "en-US"
    },
    {
     "@type": "ImageObject",
     "@id": "https://clearank.com/og/mi/stock/draftkings-dkng.png",
     "url": "https://clearank.com/og/mi/stock/draftkings-dkng.png",
     "width": "1200",
     "height": "630",
     "caption": "DraftKings Inc. (DKNG) analysis by CleaRank",
     "inLanguage": "en-US"
    },
    {
     "@type": "BreadcrumbList",
     "@id": "https://clearank.com/stock/draftkings-dkng/#breadcrumb",
     "itemListElement": [
      {
       "@type": "ListItem",
       "position": "1",
       "item": {
        "@id": "https://clearank.com",
        "name": "Home"
       }
      },
      {
       "@type": "ListItem",
       "position": "2",
       "item": {
        "@id": "https://clearank.com/stock/draftkings-dkng/",
        "name": "DraftKings (DKNG) Stock Price Analysis"
       }
      }
     ]
    },
    {
     "@type": "WebPage",
     "@id": "https://clearank.com/stock/draftkings-dkng/#webpage",
     "url": "https://clearank.com/stock/draftkings-dkng/",
     "name": "DraftKings Inc. Futures Forecast 2026: Outlook & Key Levels",
     "datePublished": "2026-06-25T09:35:38+00:00",
     "dateModified": "2026-10-22T04:51:25+00:00",
     "isPartOf": {
      "@id": "https://clearank.com/#website"
     },
     "primaryImageOfPage": {
      "@id": "https://clearank.com/og/mi/stock/draftkings-dkng.png"
     },
     "inLanguage": "en-US",
     "breadcrumb": {
      "@id": "https://clearank.com/stock/draftkings-dkng/#breadcrumb"
     },
     "reviewedBy": {
      "@id": "https://clearank.com/writer/ryan-brothwell/#person"
     }
    },
    {
     "@type": "Person",
     "@id": "https://clearank.com/writer/ryan-brothwell/#person",
     "name": "Ryan Brothwell",
     "jobTitle": "Financial Journalist",
     "url": "https://clearank.com/writer/ryan-brothwell/",
     "worksFor": {
      "@id": "https://clearank.com/#organization"
     }
    },
    {
     "@type": "Article",
     "@id": "https://clearank.com/stock/draftkings-dkng/#richSnippet",
     "headline": "DraftKings Inc. Futures Forecast 2026: Outlook & Key Levels",
     "name": "DraftKings Inc. Futures Forecast 2026: Outlook & Key Levels",
     "description": "DraftKings Inc. (DKNG) stock: Consumer Cyclical, Gambling. $10.2B market cap. AI rating, technicals, 2030 forecast and trade plans.",
     "datePublished": "2026-06-25T09:35:38+00:00",
     "dateModified": "2026-10-22T04:51:25+00:00",
     "author": {
      "@id": "https://clearank.com/#organization"
     },
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "publishingPrinciples": "https://clearank.com/editorial-code/",
     "about": {
      "@type": "Corporation",
      "name": "DraftKings Inc.",
      "identifier": [
       {
        "@type": "PropertyValue",
        "propertyID": "tickerSymbol",
        "value": "DKNG"
       },
       {
        "@type": "PropertyValue",
        "propertyID": "exchange",
        "value": "NASDAQ"
       }
      ],
      "description": "DraftKings Inc. Class A Common Stock represents the equity of DraftKings Inc., a digital sports entertainment and gaming company. DraftKings provides online and retail sports betting, iGaming, daily fantasy sports, and related gaming products for consumers in regulated markets. Its platform also inc",
      "tickerSymbol": "DKNG",
      "sameAs": "https://www.draftkings.com"
     },
     "isPartOf": {
      "@id": "https://clearank.com/stock/draftkings-dkng/#webpage"
     },
     "image": {
      "@id": "https://clearank.com/og/mi/stock/draftkings-dkng.png"
     },
     "inLanguage": "en-US",
     "mainEntityOfPage": {
      "@id": "https://clearank.com/stock/draftkings-dkng/#webpage"
     }
    }
   ]
  },
  {
   "@context": "https://schema.org",
   "@type": "FAQPage",
   "mainEntity": [
    {
     "@type": "Question",
     "name": "Is DraftKings Inc. (DKNG) a buy right now?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "A score of 27/100 gives DKNG its Sell rating. The analysts' outlook carries the score: 31 of 37 analysts rate it a buy and the median target is 51.0% above the price. The trend holds the score back, because the price is 17.01% below its 200-day average and 8.70% below its 50-day average, and the 50-day average is 9.10% below the 200-day. This describes the data on this page and is not a personal recommendation."
     }
    },
    {
     "@type": "Question",
     "name": "How has DraftKings Inc. (DKNG) performed over the past year?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Over the past year the price fell 38.94%. Over shorter periods it fell 10.07% in three months and fell 6.55% in the past month. It now trades 44.48% below its 52-week high of $36.98."
     }
    },
    {
     "@type": "Question",
     "name": "What are the key price levels for DKNG?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "On the upside, DKNG meets the 50-day SMA at $22.49 first, then the 200-day SMA at $24.74. On the downside, the 20-day EMA at $20.24 comes first, followed by the 52-week low at $18.35."
     }
    },
    {
     "@type": "Question",
     "name": "Does DKNG have a P/E ratio?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "DKNG's P/E is not meaningful, since the company posted a loss over the last 12 months. Measured on sales, its P/S of 1.58 is 16.8% under the sector median of 1.9."
     }
    },
    {
     "@type": "Question",
     "name": "What do Wall Street analysts think of DKNG?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Of the 37 analysts covering DKNG, 31 rate it buy, 5 hold and 1 sell. Their median 12-month target is $31.00, 51.0% above the current price."
     }
    },
    {
     "@type": "Question",
     "name": "How volatile is DKNG?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "On an average day DKNG's price moves 3.32%, based on the 30-day standard deviation of daily returns. Measured against the S&P 500, its beta is 1.61."
     }
    },
    {
     "@type": "Question",
     "name": "Are DKNG insiders buying or selling?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Insiders sold $86.8M of stock over the last 18 months and bought $3.2M on the open market. Insider sales are often arranged in advance or made to cover taxes on vesting shares, so they carry less weight than open-market purchases."
     }
    },
    {
     "@type": "Question",
     "name": "What is the 52-week range of DKNG?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Over the past 52 weeks DKNG has traded in a range from $18.35 to $36.98. At $20.53 it sits at 12% of that span, 11.88% above the low and 44.48% below the high."
     }
    },
    {
     "@type": "Question",
     "name": "Is DKNG in an uptrend?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "No. DraftKings Inc. (DKNG) trades at $20.53, below both its 50- and 200-day moving averages ($22.49 and $24.74). Its 14-day RSI on daily closes is 49.2, in neutral territory."
     }
    },
    {
     "@type": "Question",
     "name": "What is DKNG's biggest drop in the last 7 years?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "DraftKings Inc. (DKNG)'s worst peak-to-trough fall over the last 7 years was -85.7%, from March 2021 to May 2022 (with dividends reinvested). It has not regained that peak yet and is still 71.3% below it. Over the same period, 56% of 1-year holding periods ended with a gain."
     }
    }
   ]
  }
 ]
}